MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Betrixaban hydrochloride

CAS No. : 2099719-47-6

MCE 站：Betrixaban hydrochloride

产品活性：Betrixaban (PRT054021) hydrochloride 是一种有效的，具有口服活性的选择性 factor Xa (fXa) 抑制剂，IC₅₀ 为 1.5 nM。Betrixaban hydrochloride 具有抗血栓形成效果。

研究领域：Metabolic Enzyme/Protease

作用靶点：Factor Xa

In Vitro: Betrixaban (PRT054021) shows IC₅₀ of 8.9 μM in patch clamp hERG assays.
Betrixaban shows an IC₅₀ ａnd a K_i of 6.3 μM ａnd 3.5 μM for the plasma kallikrein, respectively.
Betrixaban (hERG K_i 1.8 μM) exhibits significantly lower hERG activity than all the others (hERG K_i0.5 μM).
Betrixaban (5-25 ng/mL) inhibits thrombin generation.

In Vivo: Betrixaban (0.5 mg/kg, i.v.; 2.5 mg/kg, p.o.) has bioavailability of 51.6% in dog.
Betrixaban (0.75 mg/kg, i.v.; 7.5 mg/kg, p.o.) has bioavailability of 58.7% in monkey.
Betrixaban mediated whole-blood INR increase is reversed by r-Antidote. After i.v. infusion for 30 min, the total plasma concentrations of Betrixaban is 0.2±0.01 μM, ａnd the percentages of unbound inhibitor is 40%±7.2%. After administration of r-Antidote, the total plasma concentration increased to 2.0±0.4 μM, ａnd the percentage of unbound inhibitor declined to 0.3%±0.1%.
Betrixaban (3 mg/kg) shows nearly comparable inhibition of thrombus mass to enoxaparin 1.6 mg/kg (76% vs 96% inhibition) in the rabbit abdominal vena cava model of clot accretion on cotton threads.
Betrixaban (19.1 mg/kg) is at least as effective at maintaining patency as enoxaparin 7.6 mg/kg ａnd clopidogrel 3 mg/kg/d (90% vs 70% vs 80% patency, respectively) in the ferric chloride injury model of rodent carotid artery.

相关产品：Heparin sodium salt  |  Apixaban  |  Rivaroxaban  |  Edoxaban  |  Fondaparinux sodium  |  Gabexate mesylate  |  Betrixaban  |  Otamixaban  |  Milvexian  |  5-R-Rivaroxaban  |  Betrixaban-d6  |  BMS-962212  |  Darexaban  |  Asundexian  |  BMS-262084  |  Delparantag  |  Edoxaban impurity 4  |  Edoxaban-d6  |  Fitusiran  |  FXIa-IN-1  |  FXIa-IN-6  |  FXIa-IN-7  |  FXIa-IN-8  |  O-Desmethyl apixaban sulfate sodium  |  Razaxaban hydrochloride

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  染料试剂  |  PROTAC  |  同位素标记物  |  寡核苷酸

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。